Arcutis Biotherapeutics, Inc. (ARQT) SEC Filings — 2025
9 SEC filings for Arcutis Biotherapeutics, Inc. (ARQT) in 2025.
Filings
- Arcutis Biotherapeutics Reports Director Departure and New Election — 8-K · Dec 8, 2025
- Arcutis Swings to Profit on Zoryve Sales Surge, Cash Dips — 10-Q · Oct 28, 2025
- Arcutis's Q2 Net Loss Widens to $78.9M Amidst R&D Push — 10-Q · Aug 6, 2025
- Arcutis Biotherapeutics Files 8-K — 8-K · Jun 17, 2025
- Arcutis Biotherapeutics Files Q1 2025 10-Q — 10-Q · May 6, 2025
- Arcutis Biotherapeutics Executive Compensation Revealed — DEF 14A · Apr 29, 2025
- Arcutis Biotherapeutics Announces Director Changes — 8-K · Apr 10, 2025
- Arcutis Biotherapeutics, Inc. 10-K Filing — 10-K · Feb 25, 2025
- Arcutis Biotherapeutics Files 8-K on Financials — 8-K · Jan 13, 2025